Zogenix Receives FDA Approval for Zohydro(TM) ER (hydrocodone bitartrate) Extended-Release Capsules
Conference Call and Webcast on Monday, October 28, at 8:30 a.m. ET
GlobeNewswirePress Release: Zogenix – 36 seconds ago
Zogenix, Inc. (ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and pain, today announced that the U.S. Food and Drug Administration (FDA) has approved ZohydroTM ER (hydrocodone bitartrate) extended-release capsules, an opioid agonist, extended-release oral formulation of hydrocodone without acetaminophen, for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Zogenix expects to launch Zohydro ER in approximately four months.
This news is catching everyone by surprise. And I mean "buy" !!!!!!!
Shorts have been caught IMHO